tradingkey.logo

Caris Life Sciences Inc

CAI
查看詳細走勢圖

33.660USD

+0.540+1.63%
收盤 09/16, 16:00美東報價延遲15分鐘
9.46B總市值
虧損本益比TTM

Caris Life Sciences Inc

33.660

+0.540+1.63%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+1.63%

5天

-0.85%

1月

-7.78%

6月

0.00%

今年開始到現在

0.00%

1年

0.00%

查看詳細走勢圖

TradingKey 股票評分

暫無公司評分資料

新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

暫無數據

營業總收入

暫無數據

公司

Caris Life Sciences Inc. is a patient-centric, next-generation artificial intelligence tech bio company and precision medicine provider. The Company develops and commercializes solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale. Its entire portfolio of precision medicine solutions is designed to benefit patients, with an initial focus on oncology, and serves the clinical, academic, and biopharma markets. Its platform is purpose-built to leverage the convergence of next-generation sequencing (NGS), artificial intelligence (AI) and machine learning (ML) technologies, and high-performance computing. Its purpose-built, proprietary multi-omic profiling solutions capture and analyze molecular information from tissue and blood in a comprehensive manner. Its services for biopharma companies include prospective and retrospective profiling services, and companion diagnostics development.
公司代碼CAI
公司Caris Life Sciences Inc
CEOMr. David Dean Halbert
網址https://www.carislifesciences.com/
KeyAI